News Hub

Build backwards: A framework for rare disease gene therapy development

  

Nicholas Ostrout, PhD
ViroCell Biologics
United States

Farzin Farzaneh, PhD, CSO
ViroCell Biologics
United States

Hilary Schultz, MS
Persephoni Biosciences, LLC.
United States


Click Here to Read Article 


#IndustryMemberNews

0 comments
28 views

Permalink